Patent AnalyticsExaminers
Menu

Topic

Epidermal growth factor Steady

290 applications whose title mentions it. Its share of new filings over the last two years is 3% above the four years before.

Allowance rate
62%
−14 pts vs the USPTO 263 decided
Months to first action
16.8 mo
−1.8 vs the USPTO
Applications
290.0
in the record
Allowed
162.0
101 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Applications

Recent applications on this topic

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19507940EXTRACELLULAR VESICLES FOR INHIBITING INTERLEUKIN 6 (IL6) TRANS-SIGNALING AND VASCU…2026-02-02Pending00n/a
19492561Antibody Against Human Epidermal Growth Factor 3, Preparation Method and Use Thereof2025-12-11Pending00n/a
19382510ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ANTIBODY-DRUG CONJUGATE AND USE THEREOF2025-11-07Pending00n/a
15272797Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15207869Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15946882Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15308364Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15827920Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15509392Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15428171Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in